TriSalus Life Sciences, Inc. (TLSI): Capital Expenditures

Annual figures by period end, from SEC filings.

$918.0K
Year ended 2025-12-31
$480.0K
Trailing 12 months to 2026-06-30
+11.9%
3-year compound annual growth
2022-12-31: $655.0K2023-12-31: $588.0K2024-12-31: $345.0K2025-12-31: $918.0K$918.0K
2022-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$918.0K+166.1%2026-03-05, From 2025-01-01
2024-12-31$345.0K-41.3%2026-03-05, From 2024-01-01
2023-12-31$588.0K-10.2%2025-05-30, From 2023-01-01
2022-12-31$655.0Kn/a2024-04-11, From 2022-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$918.0K+166.1%
SANUWAVE Health, Inc. (SNWV)2025-12-31$1.94M+296.3%
Shoulder Innovations, Inc. (SI)2025-12-31$7.41M+84.5%
SS Innovations International, Inc. (SSII)2025-12-31$3.66M+453.2%
KORU Medical Systems, Inc. (KRMD)2025-12-31$932.5K-28.1%
Carlsmed, Inc. (CARL)2025-12-31$642.0K+256.7%
Interpace Biosciences, Inc. (IDXG)2025-12-31$356.0K-59.4%
Apyx Medical Corp (APYX)2025-12-31$1.11M+54.3%
Utah Medical Products Inc (UTMD)2025-12-31$371.0K+61.3%

Compare TLSI, SNWV, SI, SSII side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗